Sprint Bioscience Ab Stock Fundamentals
SPRINT Stock | SEK 1.36 0.06 4.62% |
Sprint Bioscience AB fundamentals help investors to digest information that contributes to Sprint Bioscience's financial success or failures. It also enables traders to predict the movement of Sprint Stock. The fundamental analysis module provides a way to measure Sprint Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sprint Bioscience stock.
Sprint |
Sprint Bioscience AB Company Return On Equity Analysis
Sprint Bioscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sprint Bioscience Return On Equity | -1.09 |
Most of Sprint Bioscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sprint Bioscience AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Sprint Bioscience AB has a Return On Equity of -1.0926. This is 95.44% lower than that of the Healthcare sector and notably lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Sweden stocks is notably higher than that of the company.
Sprint Bioscience Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sprint Bioscience's current stock value. Our valuation model uses many indicators to compare Sprint Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sprint Bioscience competition to find correlations between indicators driving Sprint Bioscience's intrinsic value. More Info.Sprint Bioscience AB is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sprint Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sprint Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sprint Bioscience's earnings, one of the primary drivers of an investment's value.Sprint Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sprint Bioscience's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sprint Bioscience could also be used in its relative valuation, which is a method of valuing Sprint Bioscience by comparing valuation metrics of similar companies.Sprint Bioscience is currently under evaluation in return on equity category among related companies.
Sprint Fundamentals
Return On Equity | -1.09 | |||
Return On Asset | -0.59 | |||
Operating Margin | (76.00) % | |||
Current Valuation | 24.98 M | |||
Shares Outstanding | 69.8 M | |||
Shares Owned By Insiders | 35.31 % | |||
Shares Owned By Institutions | 2.59 % | |||
Price To Earning | 32.79 X | |||
Price To Book | 2.61 X | |||
Price To Sales | 27.09 X | |||
Revenue | 35.11 M | |||
Gross Profit | 24.59 M | |||
EBITDA | (24.22 M) | |||
Net Income | (25.08 M) | |||
Cash And Equivalents | 13.82 M | |||
Cash Per Share | 1.19 X | |||
Debt To Equity | 32.20 % | |||
Current Ratio | 2.69 X | |||
Book Value Per Share | 0.63 X | |||
Cash Flow From Operations | (40.12 M) | |||
Earnings Per Share | (0.75) X | |||
Target Price | 32.0 | |||
Number Of Employees | 34 | |||
Beta | 1.32 | |||
Market Capitalization | 53.17 M | |||
Total Asset | 79.14 M | |||
Retained Earnings | (39 M) | |||
Working Capital | 4 M | |||
Current Asset | 25 M | |||
Current Liabilities | 21 M | |||
Net Asset | 79.14 M |
About Sprint Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sprint Bioscience AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sprint Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sprint Bioscience AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden. Sprint Bioscience operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sprint Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sprint Bioscience's short interest history, or implied volatility extrapolated from Sprint Bioscience options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sprint Bioscience AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |